These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26879827)

  • 1. Can an early phase clinical pharmacology study replace a thorough QT study? Experience with a novel H3-receptor antagonist/inverse agonist.
    Shah RR; Maison-Blanche P; Robert P; Denis E; Duvauchelle T
    Eur J Clin Pharmacol; 2016 May; 72(5):533-43. PubMed ID: 26879827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing assay sensitivity in QT studies: experience with the use of moxifloxacin in an early phase clinical pharmacology study and comparison with its effect in a thorough QT study.
    Shah RR; Maison-Blanche P; Duvauchelle T; Robert P; Denis E
    Eur J Clin Pharmacol; 2015 Dec; 71(12):1451-9. PubMed ID: 26423621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Potential QT Effects of JNJ-54861911, a BACE Inhibitor in Single- and Multiple-Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration-QTc Analysis.
    Timmers M; Sinha V; Darpo B; Smith B; Brown R; Xue H; Ferber G; Streffer J; Russu A; Tritsmans L; Solanki B; Bogert J; Van Nueten L; Salvadore G; Nandy P
    J Clin Pharmacol; 2018 Jul; 58(7):952-964. PubMed ID: 29505101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing QT/QTc interval prolongation with concentration-QT modeling for Phase I studies: impact of computational platforms, model structures and confidence interval calculation methods.
    Lu J; Li J; Helmlinger G; Al-Huniti N
    J Pharmacokinet Pharmacodyn; 2018 Jun; 45(3):469-482. PubMed ID: 29556866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
    Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
    Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No effect on QT intervals of mipomersen, a 2'-O-methoxyethyl modified antisense oligonucleotide targeting ApoB-100 mRNA, in a phase I dose escalation placebo-controlled study, and confirmed by a thorough QT (tQT) study, in healthy subjects.
    Yu RZ; Gunawan R; Li Z; Mittleman RS; Mahmood A; Grundy JS; Singleton W; Geary R; Wang Y
    Eur J Clin Pharmacol; 2016 Mar; 72(3):267-75. PubMed ID: 26645588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women.
    Stier B; Fossler M; Liu F; Caltabiano S
    Clin Ther; 2015 Jul; 37(7):1541-54. PubMed ID: 26138866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No QTc Prolongation With Zanubrutinib: Results of Concentration-QTc Analysis From a Thorough QT Study in Healthy Subjects.
    Mu S; Darpo B; Tang Z; Novotny W; Tawashi M; Xue H; Willett M; Lin L; Sahasranaman S; Ou YC
    Clin Transl Sci; 2020 Sep; 13(5):923-931. PubMed ID: 32144955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase I, Randomized, Double-Blinded, Placebo- and Moxifloxacin-Controlled, Four-Period Crossover Study To Evaluate the Effect of Gepotidacin on Cardiac Conduction as Assessed by 12-Lead Electrocardiogram in Healthy Volunteers.
    Hossain M; Zhou M; Tiffany C; Dumont E; Darpo B
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appraisal of ICH E14/S7B Q&As adopted in February 2022 using thorough QT/QTc study data for α4-integrin antagonist carotegrast methyl in Japanese healthy subjects.
    Kambayashi R; Goto A; Izumi-Nakaseko H; Oikawa I; Ikeda N; Matsuda K; Takei Y; Matsumoto A; Kumagai Y; Sugiyama A
    J Pharmacol Sci; 2022 Nov; 150(3):191-199. PubMed ID: 36184124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lenvatinib (E7080) on the QTc interval: results from a thorough QT study in healthy volunteers.
    Shumaker RC; Zhou M; Ren M; Fan J; Martinez G; Aluri J; Darpo B
    Cancer Chemother Pharmacol; 2014 Jun; 73(6):1109-17. PubMed ID: 24658627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Therapeutic and Supratherapeutic Doses of Siponimod (BAF312) on Cardiac Repolarization in Healthy Subjects.
    Shakeri-Nejad K; Aslanis V; Veldandi UK; Mooney L; Pezous N; Brendani B; Juan A; Allison M; Perry R; Legangneux E
    Clin Ther; 2015 Nov; 37(11):2489-2505.e2. PubMed ID: 26519230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verinurad does not prolong QTc interval: a thorough QT study using concentration-QTc modelling.
    Parkinson J; Dota C; Källgren C; Gottfridsson C; Bjursell M; Perl S; Kӧrnicke T; Rekić D; Johansson S
    Br J Clin Pharmacol; 2023 Jun; 89(6):1747-1755. PubMed ID: 36504291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjects.
    Täubel J; Ferber G; Fox G; Fernandes S; Lorch U; Camm AJ
    Br J Clin Pharmacol; 2017 Feb; 83(2):339-348. PubMed ID: 27618796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects.
    Kelleher D; Tombs L; Preece A; Brealey N; Mehta R
    Pulm Pharmacol Ther; 2014 Oct; 29(1):49-57. PubMed ID: 25020273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IQ-CSRC prospective clinical Phase 1 study: "Can early QT assessment using exposure response analysis replace the thorough QT study?".
    Darpo B; Sarapa N; Garnett C; Benson C; Dota C; Ferber G; Jarugula V; Johannesen L; Keirns J; Krudys K; Ortemann-Renon C; Riley S; Rogers-Subramaniam D; Stockbridge N
    Ann Noninvasive Electrocardiol; 2014 Jan; 19(1):70-81. PubMed ID: 24372708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study.
    Morganroth J; Wang Y; Thorn M; Kumagai Y; Harris S; Stockbridge N; Kleiman R; Shah R
    Br J Clin Pharmacol; 2015 Sep; 80(3):446-59. PubMed ID: 26011050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay sensitivity in "Hybrid thorough QT/QTc (TQT)" study.
    Huang DP; Chen J; Dang Q; Tsong Y
    J Biopharm Stat; 2019; 29(2):378-384. PubMed ID: 30346877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prospective IQ-CSRC trial: A prototype early clinical proarrhythmia assessment investigation for replacing the ICH E14 thorough QTc (TQT) study.
    Cavero I; Holzgrefe H; Clements M
    J Pharmacol Toxicol Methods; 2016; 80():1-8. PubMed ID: 26903171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Tucatinib on Cardiac Repolarization in Healthy Volunteers.
    Topletz-Erickson AR; Mayor JG; Liu HT; Abdulrasool LI; Endres CJ
    Drugs R D; 2023 Dec; 23(4):411-419. PubMed ID: 37751113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.